CURRENT APPROACHES TO ANTIBIOTIC PROPHYLAXIS DURING TRANSURETHRAL PROSTATE RESECTION


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Transurethral resection is the “gold standard" treatment for benign prostatic hyperplasia. Investigations have indicated that postoperative infectious and inflammatory complications occur in every 5 patients. Adequate perioperative antibiotic prophylaxis significantly reduces the risk of their development.

全文:

受限制的访问

作者简介

I. Sosin

Smolensk Regional Clinical Hospital

V. Rafalsky

Smolensk State Medical Academy

Email: V.rafalskiy@mail.ru
Professor MD

A. Shevelev

Smolensk State Medical Academy

Candidate of Medical Sciences

参考

  1. Коган М.И., Рафальский В.В., Страчунский Л.С. и др. Эффективность и безопасность перорального и внутривенного применения ципрофлоксацина для антибиотикопрофилактики при трансуретральной резекции предстательной железы // Consilium Medicum. - 2006; 8 (4): 8-12.
  2. Мартов А.Г., Лопаткин Н.А., Гущин Б.Л. и др. Руководство по трансуретральной эндоскопической электрохирургии доброкачественной гиперплазии простаты (www.uroweb.ru).
  3. Саркулова М.Н. Профилактика и лечение госпитальной инфекции мочевых путей при малоинвазивных урологических вмешательствах. Автореф.. д-ра мед. наук. - М., 2009; 44 с.
  4. Страчунский Л.С., Козлов С.Н. Современная антимикробная химиотерапия. Руководство для врачей. - М.: Боргес, 2002; 436 с.
  5. Berry A., Barratt A. Prophylactic antibiotic use in transurethral prostatic resection: a meta-analysis // J. Urol. - 2002; 167: 571-7.
  6. Burke J. The effective period of preventive antibiotic action in experimental incision and dermal lesion // Surgery. - 1961; 50: 161-8.
  7. Bjerklund-Johansen T., Naber K., Tenke P. The Paneuropean prevalence study on nosocomial urinary tract infections / Eur. Ass. Urol. Vienna, Austria, 2004.
  8. Bergamini T., Polk H. The importance of tissue antibiotic activity in the prevention of operative wound infection // J. Antimicrob. Chemother. - 1989; 23: 301-13.
  9. Grabe M. Controversies in antibiotic prophylaxis in surgery // Int. J. Antimicrob. Agents. - 2004; 23 (1): 17-23.
  10. Grabe M., Bishop M., Bjerklund-Johansen T. et al. Guidelines on the Management of Urinary and Male Genital Tract Infections / Eur. Ass. Urol. - 2008; 116 р.
  11. Hedelin H., Bergman B., Frimodt-Moller C. et al. Antibiotic prophlaxis in diagnostic and therapeutic urological interventions // Nord Med. - 1995; 110: 9-11.
  12. Love T. Antibiotic prophylaxis and urologic surgery // Urol. - 1985; 26 (5): 2-5.
  13. Schito G., Naber K., Botto H. et.al. The ARESC study: an international survey on antimicrobial resistance of pathogens involved in uncomplicated urinary tract infection // Int. J. Antimicrob. Agents. - 2009; 34: 407-13.
  14. Wagenlehner F., Wagenlehner C., Schinzel S. et al. Working Group ‘Urological Infections’ of German Society of Urology. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate // Eur. Urol. - 2005; 47: 549-56.
  15. Wilson N., Lewis H. Survey of antibiotic prophylaxis in British urological practice // Br. J. Urol. - 1985; 57: 478-82.
  16. Qiang W., Jianchen W., MacDonald R. et al. Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100000 bacteria per ml: systematic review // J. Urol. - 2005; 173: 1175-81.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Russkiy Vrach Publishing House, 2012